Hepatocellular Carcinoma Clinical Trials in Créteil
3 recruitingCréteil, France
Showing 1–3 of 3 trials
Recruiting
Phase 2
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma
Centre Hospitalier Universitaire de Besancon105 enrolled14 locationsNCT05528952
Recruiting
Phase 2
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
Liver TransplantHepatocellular Carcinoma RecurrentSystemic Treatment
Assistance Publique - Hôpitaux de Paris50 enrolled10 locationsNCT06254248
Recruiting
Phase 3
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
Triple-Negative Breast CancerCervical CancerUrothelial Carcinoma+12 more
UNICANCER646 enrolled40 locationsNCT05078047